MUC16 and non-small cell lung carcinoma: Increased MUC1, MUC3A, MUC5AC, MUC5B, MUC12, MUC16, and MUC22 mRNA expressions correlated with unfavourable DFS in NSCLC patients (Figure 5(b)).